Relation of C-reactive protein levels to instability of untreated vulnerable coronary plaques (from the PROSPECT study)

American Journal of Cardiology

Volumn 114, Issue 3, 2014, Pages 376-383

  Kelly, Christopher R ^a   Weisz, Giora ^b   Maehara, Akiko ^a   Mintz, Gary S ^a   Mehran, Roxana ^c   Lansky, Alexandra J ^d   Parise, Helen ^a   De Bruyne, Bernard ^e   Serruys, Patrick W ^f   Stone, Gregg W ^a  

^a Department of Medicine   (United States)

^b SHAARE ZEDEK MEDICAL CENTER   (Israel)

^c CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e OLV HOSPITAL   (Belgium)

^f ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

ACUTE CORONARY SYNDROME; ANGIOCARDIOGRAPHY; ARTERY INTIMA PROLIFERATION; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; FOLLOW UP; GRAY SCALE INTRAVASCULAR ULTRASOUND; HEART ARREST; HEART DEATH; HEART DISEASE; HEART INFARCTION; HUMAN; INTRAVASCULAR ULTRASOUND; INTRAVASCULAR ULTRASOUND SYSTEM; MAJOR CLINICAL STUDY; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; NONCULPRIT LESION; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIOFREQUENCY; RADIOFREQUENCY INTRAVASCULAR ULTRASOUND; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; UNSTABLE ANGINA PECTORIS; WAIST CIRCUMFERENCE;

AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DISEASE PROGRESSION; FEMALE; HUMANS; INCIDENCE; INFLAMMATION; MALE; MIDDLE AGED; PLAQUE, ATHEROSCLEROTIC; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TIME FACTORS; WORLD HEALTH;

EID: 84904252172     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2014.04.048     Document Type: Article

References (29)

1. G.K. Hansson Inflammation, atherosclerosis, and coronary artery disease N Engl J Med 352 2005 1685 1695
2. J. Danesh, J.G. Wheeler, G.M. Hirschfield, S. Eda, G. Eiriksdottir, A. Rumley, G.D. Lowe, M.B. Pepys, and V. Gudnason C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease N Engl J Med 350 2004 1387 1397
3. P.M. Ridker, C.P. Cannon, D. Morrow, N. Rifai, L.M. Rose, C.H. McCabe, M.A. Pfeffer, E. Braunwald Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) Investigators C-reactive protein levels and outcomes after statin therapy N Engl J Med 352 2005 20 28
4. J.S. Zebrack, J.B. Muhlestein, B.D. Horne, and J.L. Anderson C-reactive protein and angiographic coronary artery disease: independent and additive predictors of risk in subjects with angina J Am Coll Cardiol 39 2002 632 637
5. B.D. Johnson, K.E. Kip, O.C. Marroquin, P.M. Ridker, S.F. Kelsey, L.J. Shaw, C.J. Pepine, B. Sharaf, C.N. Bairey Merz, G. Sopko, M.B. Olson, and S.E. Reis Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women: the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Circulation 109 2004 726 732
6. R.F. Redberg, N. Rifai, L. Gee, and P.M. Ridker Lack of association of C-reactive protein and coronary calcium by electron beam computed tomography in postmenopausal women: implications for coronary artery disease screening J Am Coll Cardiol 36 2000 39 43
7. R. Virmani, A.P. Burke, A. Farb, and F.D. Kolodgie Pathology of the vulnerable plaque J Am Coll Cardiol 47 2006 C13 C18
8. G.W. Stone, A. Maehara, A.J. Lansky, B. de Bruyne, E. Cristea, G.S. Mintz, R. Mehran, J. McPherson, N. Farhat, S.P. Marso, H. Parise, B. Templin, R. White, Z. Zhang, and P.W. Serruys A prospective natural-history study of coronary atherosclerosis N Engl J Med 364 2011 226 235
9. A. Maehara, E. Cristea, G.S. Mintz, A.J. Lansky, O. Dressler, S. Biro, B. Templin, R. Virmani, B. de Bruyne, P.W. Serruys, and G.W. Stone Definitions and methodology for the grayscale and radiofrequency intravascular ultrasound and coronary angiographic analyses JACC Cardiovasc Imaging 5 2012 S1 S9
10. H.M. García-García, G.S. Mintz, A. Lerman, D.G. Vince, M.P. Margolis, G.A. van Es, M.A. Morel, A. Nair, R. Virmani, A.P. Burke, G.W. Stone, and P.W. Serruys Tissue characterisation using intravascular radiofrequency data analysis: recommendations for acquisition, analysis, interpretation and reporting EuroIntervention 5 2009 177 189
11. C. Mueller, H.J. Buettner, J.M. Hodgson, S. Marsch, A.P. Perruchoud, H. Roskamm, and F.J. Neumann Inflammation and long-term mortality after non-ST elevation acute coronary syndrome treated with a very early invasive strategy in 1042 consecutive patients Circulation 105 2002 1412 1415
12. B. Lindahl, H. Toss, A. Siegbahn, P. Venge, and L. Wallentin Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease N Engl J Med 343 2000 1139 1147
13. P.M. Ridker, and N. Cook Clinical usefulness of very high and very low levels of C-reactive protein across the full range of Framingham Risk Scores Circulation 109 2004 1955 1959
14. M. Naghavi, P. Libby, E. Falk, S.W. Casscells, S. Litovsky, J. Rumberger, J.J. Badimon, C. Stefanadis, P. Moreno, G. Pasterkamp, Z. Fayad, P.H. Stone, S. Waxman, P. Raggi, M. Madjid, A. Zarrabi, A. Burke, C. Yuan, P.J. Fitzgerald, D.S. Siscovick, C.L. de Korte, M. Aikawa, K.E. Juhani Airaksinen, G. Assmann, C.R. Becker, J.H. Chesebro, A. Farb, Z.S. Galis, C. Jackson, I.K. Jang, W. Koenig, R.A. Lodder, K. March, J. Demirovic, M. Navab, S.G. Priori, M.D. Rekhter, R. Bahr, S.M. Grundy, R. Mehran, A. Colombo, E. Boerwinkle, C. Ballantyne, W. Insull Jr., R.S. Schwartz, R. Vogel, P.W. Serruys, G.K. Hansson, D.P. Faxon, S. Kaul, H. Drexler, P. Greenland, J.E. Muller, R. Virmani, P.M. Ridker, D.P. Zipes, P.K. Shah, and J.T. Willerson From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I Circulation 108 2003 1664 1672
15. J. Zacho, A. Tybjaerg-Hansen, J.S. Jensen, P. Grande, H. Sillesen, and B.G. Nordestgaard Genetically elevated C-reactive protein and ischemic vascular disease N Engl J Med 359 2008 1897 1908
16. P.M. Ridker Testing the inflammatory hypothesis of atherothrombosis: scientific rationale for the cardiovascular inflammation reduction trial (CIRT) J Thromb Haemost 7 Suppl 1 2009 332 339
17. P.M. Ridker, T. Thuren, A. Zalewski, and P. Libby Interleukin-1beta inhibition and the prevention of recurrent cardiovascular events: rationale and design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS) Am Heart J 162 2011 597 605
18. I. Kushner, M.L. Broder, and D. Karp Control of the acute phase response. Serum C-reactive protein kinetics after acute myocardial infarction J Clin Invest 61 1978 235 242
19. F.C. de Beer, C.R. Hind, K.M. Fox, R.M. Allan, A. Maseri, and M.B. Pepys Measurement of serum C-reactive protein concentration in myocardial ischaemia and infarction Br Heart J 47 1982 239 243
20. S. Orn, C. Manhenke, T. Ueland, J.K. Damas, T.E. Mollnes, T. Edvardsen, P. Aukrust, and K. Dickstein C-reactive protein, infarct size, microvascular obstruction, and left-ventricular remodelling following acute myocardial infarction Eur Heart J 30 2009 1180 1186
21. D.E. King, A.G. Mainous 3rd, T.A. Buchanan, and W.S. Pearson C-reactive protein and glycemic control in adults with diabetes Diabetes Care 26 2003 1535 1539
22. L.A. Bazzano, J. He, P. Muntner, S. Vupputuri, and P.K. Whelton Relationship between cigarette smoking and novel risk factors for cardiovascular disease in the United States Ann Intern Med 138 2003 891 897
23. I.S. Anand, R. Latini, V.G. Florea, M.A. Kuskowski, T. Rector, S. Masson, S. Signorini, P. Mocarelli, A. Hester, R. Glazer, and J.N. Cohn C-reactive protein in heart failure: prognostic value and the effect of valsartan Circulation 112 2005 1428 1434
24. G. Liuzzo, L.M. Biasucci, J.R. Gallimore, R.L. Grillo, A.G. Rebuzzi, M.B. Pepys, and A. Maseri The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina N Engl J Med 331 1994 417 424
25. K.O. Pietila, A.P. Harmoinen, J. Jokiniitty, and A.I. Pasternack Serum C-reactive protein concentration in acute myocardial infarction and its relationship to mortality during 24 months of follow-up in patients under thrombolytic treatment Eur Heart J 17 1996 1345 1349
26. D.A. Morrow, N. Rifai, E.M. Antman, D.L. Weiner, C.H. McCabe, C.P. Cannon, and E. Braunwald C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis in Myocardial Infarction J Am Coll Cardiol 31 1998 1460 1465
27. T. Anzai, T. Yoshikawa, H. Shiraki, Y. Asakura, M. Akaishi, H. Mitamura, and S. Ogawa C-reactive protein as a predictor of infarct expansion and cardiac rupture after a first Q-wave acute myocardial infarction Circulation 96 1997 778 784
28. H. Tomoda, and N. Aoki Prognostic value of C-reactive protein levels within six hours after the onset of acute myocardial infarction Am Heart J 140 2000 324 328
29. T. Kubo, A. Maehara, G.S. Mintz, H. Doi, K. Tsujita, S.Y. Choi, O. Katoh, K. Nasu, A. Koenig, M. Pieper, J.H. Rogers, W. Wijns, D. Bose, M.P. Margolis, J.W. Moses, G.W. Stone, and M.B. Leon The dynamic nature of coronary artery lesion morphology assessed by serial virtual histology intravascular ultrasound tissue characterization J Am Coll Cardiol 55 2010 1590 1597